Paclitaxel-terminated peptide brush polymers

In this paper, we report the preparation of paclitaxel-terminated peptide brush polymers wherein cell uptake and toxicity are tunable based on peptide sequence. Synthesis was enabled using a new paclitaxel-containing chain termination agent for ring-opening metathesis polymerization (ROMP). Critical...

Full description

Saved in:
Bibliographic Details
Published inChemical communications (Cambridge, England) Vol. 56; no. 5; pp. 6778 - 6781
Main Authors Zhu, Jialei, Sun, Hao, Callmann, Cassandra E, Thompson, Matthew P, Battistella, Claudia, Proetto, Maria T, Carlini, Andrea S, Gianneschi, Nathan C
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 23.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this paper, we report the preparation of paclitaxel-terminated peptide brush polymers wherein cell uptake and toxicity are tunable based on peptide sequence. Synthesis was enabled using a new paclitaxel-containing chain termination agent for ring-opening metathesis polymerization (ROMP). Critically, reverse phase HPLC could be used to efficiently separate peptide brush polymers consisting of one fluorophore and one terminal paclitaxel from crude polymer mixtures. These purified terminally-modified polymers showed greater potency than the original mixtures. Drug-terminated peptide brush polymers carrying positive charges exhibited enhanced cell uptake and cytotoxicity as compared to their neutral and negatively charged analogues. In this paper, we report the preparation of paclitaxel-terminated peptide brush polymers wherein cell uptake and toxicity are tunable based on peptide sequence.
Bibliography:10.1039/c9cc10023g
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1359-7345
1364-548X
DOI:10.1039/c9cc10023g